Pierre V. Trân
Corporate Officer/Principal presso Duke University
Profilo
Dr. Pierre V.
Trân, MD, is Chief Medical Officer at Euthymics Bioscience, Inc., an Assistant Consulting Professor at Duke University, a Member at American Psychiatric Association, and a Member at Society of Biological Psychiatry.
Dr. Trân was previously employed as Chief Medical Officer & VP-Clinical Development by Cortex Pharmaceuticals, Inc., Chief Medical Officer & Senior Vice President by XenoPort, Inc., Global Medical Director-Joint Antidepressant Group by Eli Lilly & Co., and Executive Officer by Neurovance, Inc.
He received his undergraduate degree from Duke University, a graduate degree from Tulane University (Louisiana), and a doctorate degree from Université de Franche-Comté.
Posizioni attive di Pierre V. Trân
| Società | Posizione | Inizio |
|---|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
American Psychiatric Association
 American Psychiatric Association Miscellaneous Commercial ServicesCommercial Services The American Psychiatric Association is the largest scientific and professional organization of psychiatrists. The private company is based in Arlington, VA and has subsidiaries in the United States. The company works together to ensure humane care and effective treatment for all individuals with mental illness, including substance use disorders. Marketa Wills has been the CEO of the company since 2024. | Corporate Officer/Principal | - |
| Society of Biological Psychiatry | Corporate Officer/Principal | - |
Precedenti posizioni note di Pierre V. Trân
| Società | Posizione | Fine |
|---|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Direttore Tecnico/Scientifico/R&S | 10/08/2010 |
| XENOPORT, INC. | Direttore Tecnico/Scientifico/R&S | 01/10/2007 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/07/2004 |
Neurovance, Inc.
 Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Euthymics Bioscience, Inc.
 Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Pierre V. Trân
| Duke University | Undergraduate Degree |
| Université de Franche-Comté | Doctorate Degree |
| Tulane University (Louisiana) | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| RESPIRERX PHARMACEUTICALS INC. | Health Technology |
| Aziende private | 5 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
American Psychiatric Association
American Psychiatric Association Miscellaneous Commercial ServicesCommercial Services The American Psychiatric Association is the largest scientific and professional organization of psychiatrists. The private company is based in Arlington, VA and has subsidiaries in the United States. The company works together to ensure humane care and effective treatment for all individuals with mental illness, including substance use disorders. Marketa Wills has been the CEO of the company since 2024. | Commercial Services |
| Society of Biological Psychiatry | |
Euthymics Bioscience, Inc.
Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Commercial Services |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- Pierre V. Trân
